Publicaciones en colaboración con investigadores/as de Hammersmith Hospital (35)

2024

  1. Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease

    Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4

2023

  1. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study

    The Lancet. Oncology, Vol. 24, Núm. 12, pp. 1411-1422

  2. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

    ESMO Open, Vol. 8, Núm. 3

2022

  1. De Novo Malignancy after Liver Transplantation: Risk Assessment, Prevention, and Management - Guidelines from the ILTS-SETH Consensus Conference

    Transplantation, Vol. 106, Núm. 1, pp. E30-E45

  2. Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus

    ESMO Open, Vol. 7, Núm. 2

  3. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2021

  1. ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors

    International Journal of Gynecological Cancer, Vol. 31, Núm. 7, pp. 961-982

  2. ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors

    Ultrasound in Obstetrics and Gynecology

  3. Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

    Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 66-78

2020

  1. In utero and childhood exposure to tobacco smoke and multi-layer molecular signatures in children

    BMC Medicine, Vol. 18, Núm. 1

2018

  1. Is there a role for HIPEC in ovarian cancer?

    Archives of Gynecology and Obstetrics

2017

  1. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

    The Lancet Oncology, Vol. 18, Núm. 9, pp. 1159-1171

  2. Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation

    Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380

  3. Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: Expert consensus

    Journal of Gastrointestinal Oncology, Vol. 8, Núm. 6, pp. 1079-1099

2015

  1. Cost-effectiveness of selective internal radiation therapy using yttrium-90 resin microspheres in treating patients with inoperable colorectal liver metastases in the UK

    Journal of Medical Economics, Vol. 18, Núm. 10, pp. 797-804

2014

  1. Sulforaphane pretreatment prevents systemic inflammation and renal injury in response to cardiopulmonary bypass

    Journal of Thoracic and Cardiovascular Surgery, Vol. 148, Núm. 2

2012

  1. Integrating radioembolization ( 90Y Microspheres) into current treatment options for liver tumors: Introduction to the international working group report

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 35, Núm. 1, pp. 81-90

  2. Integrating radioembolization into the treatment paradigm for metastatic neuroendocrine tumors in the liver

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 35, Núm. 4, pp. 393-398

  3. Integrating radioembolization with chemotherapy in the treatment paradigm for unresectable colorectal liver metastases

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 35, Núm. 3, pp. 293-301

  4. Radioembolization for the treatment of liver tumors: General principles

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 35, Núm. 1, pp. 91-99